• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gold Moves Lower; Pilgrim's Pride Earnings Top Views

    2/26/24 2:30:04 PM ET
    $ACON
    $AGTI
    $AKLI
    $LUNR
    Medical Specialities
    Health Care
    Managed Health Care
    Health Care
    Get the next $ACON alert in real time by email

    U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Monday.

    The Dow traded down 0.08% to 39,101.76 while the NASDAQ rose 0.04% to 16,003.09. The S&P 500 also fell, dropping, 0.24% to 5,076.80.

    Check This Out: Intuitive Machines, Marriott International And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Energy shares rose by 0.5% on Monday.

    In trading on Monday, utilities shares fell by 1.7%.

     

    Top Headline

     

    Pilgrim's Pride Corporation (NASDAQ:PPC) posted better-than-expected fourth-quarter results.

    Pilgrims Pride reported fourth-quarter fiscal 2023 sales growth of 9.7% year-over-year to $4.528 billion, beating the consensus of $4.47 billion. Adjusted EPS was 59 cents, an improvement from a loss of 49 cents, above the consensus of 40 cents.

     

    Equities Trading UP

     

    Akili, Inc. (NASDAQ:AKLI) shares shot up 116% to $0.4782 after the company reported positive results from Shionogi's Phase 3 clinical trial of localized version of Akili's EndeavorRx® for Pediatric ADHD patients in Japan.

    Shares of Interactive Strength Inc. (NASDAQ:TRNR) got a boost, surging 41% to $0.9299 after the company announced it has entered into an exclusive worldwide distribution agreement with WOODWAY to sell and distribute CLMBR.

    Agiliti, Inc. (NYSE:AGTI) shares were also up, gaining 29% to $9.86 after the company announced it will be taken private by THL Partners.

     

    Equities Trading DOWN

     

    Aclarion, Inc. (NASDAQ:ACON) shares dropped 65% to $0.3134 after the company priced its public offering of 5.175 million units. Each unit includes one share of common stock (or a pre-funded warrant), and two common warrants.

    Shares of Intuitive Machines, Inc. (NASDAQ:LUNR) were down 38% to $5.97 after the company said its lunar lander may have tipped over upon landing on the moon.

    Venus Concept Inc. (NASDAQ:VERO) was down, falling 25% to $0.98 after the company announced a $1.2 million registered direct offering at $1.465 per share.

    Also Check This Out: Jim Cramer: Unity Software 'Had Problems,' But Zscaler Is A 'Good One' To Buy

     

    Commodities

     

    In commodity news, oil traded up 1.8% to $77.84 while gold traded down 0.6% at $2,037.70.

    Silver traded down 2.1% to $22.505 on Monday while copper fell 1.5% to $3.8430.

     

    Euro zone

     

    European shares closed mixed today. The eurozone’s STOXX 600 fell 0.37%, London’s FTSE 100 fell 0.29% while Spain’s IBEX 35 Index rose 0.08% The German DAX gained 0.02% French CAC 40 fell 0.46% while Italy’s FTSE MIB Index fell 0.44%.

    Producer prices in Spain declined by 3.8% year-over-year in January following a 6.3% fall in the earlier month.

     

    Asia Pacific Markets

     

    Asian markets closed mostly lower on Monday, with Japan’s Nikkei 225 gaining 0.35%, Hong Kong’s Hang Seng Index falling 0.54%, China’s Shanghai Composite Index dipping 0.93% and India’s S&P BSE Sensex falling 0.4%.

    Singapore’s manufacturing production gained 1.1% year-over-year in January following a revised 2.4% decline in December.

     

    Economics

     

    Building permits in the U.S. fell by 0.3% to an annual rate of 1.489 million in January.

    The Federal Reserve Bank of Dallas’s general business activity index for manufacturing in Texas rose to -11.3 in February versus an eight-month low level of -27.4 in the previous month.

    Sales of new single-family houses in the US. climbed by 1.5% from the prior month to an annualized rate of 661,000 in January.

    Now Read This: Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $AGTI
    $AKLI
    $LUNR

    CompanyDatePrice TargetRatingAnalyst
    Intuitive Machines Inc.
    $LUNR
    1/9/2026$20.00Buy → Hold
    Stifel
    Intuitive Machines Inc.
    $LUNR
    12/19/2025$20.00Overweight
    KeyBanc Capital Markets
    Intuitive Machines Inc.
    $LUNR
    11/3/2025$18.00Buy
    Stifel
    Intuitive Machines Inc.
    $LUNR
    10/17/2025$18.00Hold → Buy
    Deutsche Bank
    Intuitive Machines Inc.
    $LUNR
    7/22/2025$17.00Buy
    Craig Hallum
    Pilgrim's Pride Corporation
    $PPC
    6/23/2025$50.00Neutral
    Goldman
    Intuitive Machines Inc.
    $LUNR
    5/22/2025$13.00Equal Weight
    Barclays
    Intuitive Machines Inc.
    $LUNR
    2/25/2025$18.00Hold
    Deutsche Bank
    More analyst ratings

    $ACON
    $AGTI
    $AKLI
    $LUNR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pilgrim's Pride Reports Fourth Quarter and Year-End 2025 Results

    GREELEY, Colo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Pilgrim's Pride Corporation (NASDAQ:PPC), one of the world's leading food companies, reports its fourth quarter and year-end 2025 financial results. 2025 Highlights Net Sales of $18.5 billion.Consolidated GAAP Operating Income margin of 8.7%.GAAP Net Income of $1.1 billion and GAAP EPS of $4.54. Adjusted Net Income of $1.2 billion, and Adjusted EPS of $5.17.Adjusted EBITDA of $2.3 billion, or a 12.3% margin, with Adjusted EBITDA margins of 14.8% in the U.S., 8.4% in Europe, and 8.8% in Mexico.Pilgrim's U.S. Fresh portfolio benefited from robust demand across retail and foodservice. Volume from Key Customers in both Case Ready and Small Bi

    2/11/26 4:44:23 PM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    Aclarion Publishes 2026 Shareholder Letter from the Chairman

    Company anticipates no capital raises prior to expected value enhancing catalysts Cash runway into 2028ATM terminated in early 2025 and ELOC expired December 31, 2025 BROOMFIELD, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the release of its 2026 Shareholder Letter from the Chairman. The letter outlines significant clinical, financial, and operational priorities as the company advances toward an expected initia

    2/5/26 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation

    Expands availability of Nociscan in the greater Los Angeles areaReinforces Nociscan's non-invasive advantage with real-world clinical validation compared to anesthetic discography, a spinal injection procedureSupports scalable growth strategy while building data assets critical to payer and provider adoption BROOMFIELD, Colo., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today it has established an agreement with Source Heal

    2/3/26 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AGTI
    $AKLI
    $LUNR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intuitive Machines downgraded by Stifel with a new price target

    Stifel downgraded Intuitive Machines from Buy to Hold and set a new price target of $20.00

    1/9/26 8:50:12 AM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    KeyBanc Capital Markets initiated coverage on Intuitive Machines with a new price target

    KeyBanc Capital Markets initiated coverage of Intuitive Machines with a rating of Overweight and set a new price target of $20.00

    12/19/25 8:48:41 AM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    Stifel initiated coverage on Intuitive Machines with a new price target

    Stifel initiated coverage of Intuitive Machines with a rating of Buy and set a new price target of $18.00

    11/3/25 9:08:29 AM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    $ACON
    $AGTI
    $AKLI
    $LUNR
    SEC Filings

    View All

    SEC Form 10-K filed by Pilgrim's Pride Corporation

    10-K - PILGRIMS PRIDE CORP (0000802481) (Filer)

    2/12/26 7:28:22 AM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    Pilgrim's Pride Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - PILGRIMS PRIDE CORP (0000802481) (Filer)

    2/11/26 9:54:59 PM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    Pilgrim's Pride Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PILGRIMS PRIDE CORP (0000802481) (Filer)

    2/11/26 9:54:48 PM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    $ACON
    $AGTI
    $AKLI
    $LUNR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Ness Brent bought $62 worth of shares (10 units at $6.20), increasing direct ownership by 1,000% to 11 units (SEC Form 4)

    4 - Aclarion, Inc. (0001635077) (Issuer)

    12/1/25 5:00:02 PM ET
    $ACON
    Medical Specialities
    Health Care

    Director Blitzer Michael bought $2,190,435 worth of shares (241,080 units at $9.09), increasing direct ownership by 14% to 1,931,248 units (SEC Form 4)

    4 - Intuitive Machines, Inc. (0001844452) (Issuer)

    11/13/25 7:15:03 PM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    $ACON
    $AGTI
    $AKLI
    $LUNR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & Chief Technology Officer Crain Timothy Price Ii was granted 84,517 shares, increasing direct ownership by 28% to 382,952 units (SEC Form 4)

    4 - Intuitive Machines, Inc. (0001844452) (Issuer)

    2/9/26 8:16:41 PM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    Officer Vontur Steven was granted 20,284 shares, increasing direct ownership by 20% to 121,390 units (SEC Form 4)

    4 - Intuitive Machines, Inc. (0001844452) (Issuer)

    2/9/26 8:16:28 PM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    Chief Executive Officer Altemus Stephen J was granted 236,647 shares, increasing direct ownership by 23% to 1,263,049 units (SEC Form 4)

    4 - Intuitive Machines, Inc. (0001844452) (Issuer)

    2/9/26 8:16:14 PM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    $ACON
    $AGTI
    $AKLI
    $LUNR
    Financials

    Live finance-specific insights

    View All

    Pilgrim's Pride Reports Fourth Quarter and Year-End 2025 Results

    GREELEY, Colo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Pilgrim's Pride Corporation (NASDAQ:PPC), one of the world's leading food companies, reports its fourth quarter and year-end 2025 financial results. 2025 Highlights Net Sales of $18.5 billion.Consolidated GAAP Operating Income margin of 8.7%.GAAP Net Income of $1.1 billion and GAAP EPS of $4.54. Adjusted Net Income of $1.2 billion, and Adjusted EPS of $5.17.Adjusted EBITDA of $2.3 billion, or a 12.3% margin, with Adjusted EBITDA margins of 14.8% in the U.S., 8.4% in Europe, and 8.8% in Mexico.Pilgrim's U.S. Fresh portfolio benefited from robust demand across retail and foodservice. Volume from Key Customers in both Case Ready and Small Bi

    2/11/26 4:44:23 PM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    Pilgrim's Pride Corporation to Host Year End 2025 Earnings Call on February 12

    GREELEY, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pilgrim's Pride Corporation (NASDAQ:PPC) announced today that it will release its fourth quarter and fiscal year 2025 financial results after the U.S. market closes on Wednesday, February 11. The company's executives will review the results on a conference call and webcast on Thursday, February 12, 2026, at 7:00 a.m. MT (9:00 a.m. ET). Prepared remarks regarding the company's financial and operational results will be followed by a question and answer period with the Pilgrim's executive management team. A press release and supplemental materials will be issued before the market opens that morning.   Investors and analysts may pre-register f

    1/20/26 5:19:45 PM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    Intuitive Machines to Acquire Lanteris Space Systems, Creating the Next-Generation Commercial, Civil, and National Security Space Prime

    The combined entity revenue exceeds $850 million*, with positive Adjusted EBITDA*, and $920 million* in backlog Expedites and enhances delivery against key existing contracts, including Near Space Network Services Expands Intuitive Machines' data services business from lunar and Earth-based operations into LEO, MEO, GEO, Moon, Mars, and deep space missions Strengthens the Company's position to prime future National Security Space (Golden Dome and Space Development Agency's Layered Architecture), Civil Space (Artemis, LTVS, and Mars), and commercial space programs HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (NASDAQ:LUNR, "Intuitive Machines, " or the "Company"))

    11/4/25 6:00:49 AM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    $ACON
    $AGTI
    $AKLI
    $LUNR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Intuitive Machines Inc.

    SC 13D/A - Intuitive Machines, Inc. (0001844452) (Subject)

    11/20/24 5:01:02 PM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Intuitive Machines Inc.

    SC 13G/A - Intuitive Machines, Inc. (0001844452) (Subject)

    11/14/24 7:05:51 PM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Intuitive Machines Inc.

    SC 13G/A - Intuitive Machines, Inc. (0001844452) (Subject)

    11/14/24 7:02:54 PM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    $ACON
    $AGTI
    $AKLI
    $LUNR
    Leadership Updates

    Live Leadership Updates

    View All

    Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

    Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companiesStrong track record of launching breakthrough technologies across spine, neurosurgery and pain managementStrengthens Aclarion's commercial execution as the Company expands adoption and payer engagement across the Eastern U.S. BROOMFIELD, Colo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the

    12/2/25 8:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion

    Marks Aclarion's first commercial sales hire with seasoned HealthTech leader and proven track record of advancing musculoskeletal imaging and spinal surgeryExperiencing strong commercial traction in UK as first market worldwide with private insurers covering NociscanNociscan reimbursed by three of top four private insurers in UK, giving access to more than 5.2 million covered lives BROOMFIELD, Colo., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announc

    11/5/25 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    Aclarion Appoints Greg Gould as Chief Financial Officer

    HealthTech CFO with extensive public company experience building organizations for growth and value creation Demonstrated success in raising capital, driving profitability, and scaling operations to $500M revenue while ensuring compliance and strengthening financial integrity BROOMFIELD, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced the appointment of Greg Gould as Chief Financial Officer (CFO), effective immediately. Greg brings mor

    9/3/25 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care